Longboard Pharmaceuticals, Inc.

CIK 1832168 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Longboard Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2025SCHEDULE 13G/A0000905148-25-000680
Feb 14, 2025SCHEDULE 13G/A0001415889-25-004291
Feb 11, 2025SCHEDULE 13G/A0000908834-25-000059
Dec 12, 202415-12G0001140361-24-049089
Dec 10, 2024RW WD0001140361-24-048900
Dec 10, 2024POSASR0001140361-24-048905
Dec 9, 2024EFFECT9999999995-24-003702
Dec 9, 2024EFFECT9999999995-24-003703
Dec 9, 2024EFFECT9999999995-24-003705
Dec 2, 202440001415889-24-028022
Dec 2, 2024S-8 POS0001140361-24-048148
Dec 2, 2024S-8 POS0001140361-24-048147
Dec 2, 2024S-8 POS0001140361-24-048145
Dec 2, 202440001415889-24-028026
Dec 2, 202440001415889-24-028025
Dec 2, 2024POS AM0001140361-24-048137
Dec 2, 202440001415889-24-028028
Dec 2, 2024S-8 POS0001140361-24-048146
Dec 2, 2024RW0001140361-24-048163
Dec 2, 202440001415889-24-028027
Dec 2, 202440001415889-24-028021
Dec 2, 202425-NSE0001354457-24-000898
Dec 2, 202440001415889-24-028024
Dec 2, 2024POS AM0001140361-24-048135
Dec 2, 20248-K0001140361-24-048133